Skip to main content
Home
FULL MENU Close Menu
Home
Home

Susan London

News

Two different radiation boost strategies reduce local failures in NSCLC

Author:
Susan London
Publish date: December 24, 2020

The two strategies – one delivering a boost to the whole tumor and the other delivering a boost only to the...

  • Read More

News

Long-term APBI cosmetic, toxicity data reported

Author:
Susan London
Publish date: December 23, 2020

Compared with whole-breast irradiation, APBI delivered with 3D-conformal radiotherapy yielded slightly poorer 5-...

  • Read More

News

Pregnancy after breast cancer is rockier but doesn’t increase recurrence risk

Author:
Susan London
Publish date: December 11, 2020

Compared with the general population, breast cancer survivors were less likely to conceive and more likely to...

  • Read More

News

Focal radiation boost nets better outcomes in prostate cancer

Author:
Susan London
Publish date: December 10, 2020

Adding a boost to the visible tumor on MRI reduced the 5-year risk of biochemical recurrence or death by nearly half, without increasing late...

  • Read More

News

Breast surgery may be a gateway to addictive medication use

Author:
Susan London
Publish date: December 9, 2020

More than 13% of women who underwent a mastectomy with reconstruction became persistent users of opioids and/or sedative-hypnotic drugs thereafter...

  • Read More

News

‘Impressive’ results with neoadjuvant T-VEC in advanced melanoma

Author:
Susan London
Publish date: December 7, 2020

Superior outcomes with intralesional T-VEC plus surgery persisted at 3 years.

  • Read More

News

Immune checkpoint inhibitors don’t increase COVID-19 incidence or mortality, studies suggest

Author:
Susan London
Publish date: November 25, 2020

Cancer patients treated with immune checkpoint inhibitors are not significantly more likely to develop or die from COVID-19, two studies suggest...

  • Read More

News

Neoadjuvant immunotherapy combo produces high response rate in melanoma

Author:
Susan London
Publish date: November 25, 2020

Final results of the Neo-C-Nivo trial show a 70% pathologic response rate in patients with high-risk resectable...

  • Read More

News

Immunotherapy could fill unmet need in leptomeningeal metastases

Author:
Susan London
Publish date: November 20, 2020

More than a third of patients had a CNS response to systemically administered pembrolizumab, including two patients who had long-lived complete...

  • Read More

News

Risk factors for severe immune-related AEs identified

Author:
Susan London
Publish date: November 19, 2020

A nationwide cohort study of more than 14,000 patients finds combination immune checkpoint inhibitor therapy, younger age, and a lung cancer...

  • Read More

News

Predictors of upstaging on PSMA PET/CT may help guide its use

Author:
Susan London
Publish date: November 16, 2020

Patients with high-risk prostate cancer having more positive cores on biopsy or a higher Gleason grade were most likely to experience upstaging...

  • Read More

News

Lung cancer: Proton beam radiotherapy likely reduces cardiovascular events

Author:
Susan London
Publish date: November 13, 2020

A retrospective study shows lower rates of transient ischemic attack and MI with proton beam radiotherapy.

  • Read More

News

Family planning issues loom large for female radiation oncologists

Author:
Susan London
Publish date: November 3, 2020

Nearly three-quarters of survey respondents said their career choice strongly influenced when they started or planned to start their family.

  • Read More

News

Molecular features of medulloblastoma may help personalize radiotherapy

Author:
Susan London
Publish date: November 2, 2020

The impact of different radiation-reducing strategies varied across four molecular subgroups.

  • Read More

News

PET guidance for radiation therapy improves prostate cancer outcomes

Author:
Susan London
Publish date: October 29, 2020

Using PET as well as conventional imaging to guide postprostatectomy radiation therapy reduces the risk of treatment failure.

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »

Privacy Policy

Terms of Use

Editorial Policy

Cookie Policy

Ad Policy

Medscape Customer Support

Frequently Asked Questions

 

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright  © 2022 Frontline Medical Communications Inc., Newark, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close